Amir Nashat's Net Worth

$310 Thousand

Estimate Recalculated Apr 11, 2025 09:46PM EST

Who is Amir Nashat

Amir Nashat does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Morphic Holding, Inc., BIND Therapeutics, Inc, Receptos, Inc., Scholar Rock Holding Corp, FATE THERAPEUTICS INC, SELECTA BIOSCIENCES INC, Metacrine, Inc., Syros Pharmaceuticals, Inc., and aTYR PHARMA INC.

SEC CIK

Amir Nashat's CIK is 0001575843

Past Insider Trading and Trends

2021 was Amir Nashat's most active year for acquiring shares with 7 total transactions. Amir Nashat's most active month to acquire stocks was the month of May. 2024 was Amir Nashat's most active year for disposing of shares, totalling 7 transactions. Amir Nashat's most active month to dispose stocks was the month of July. 2023 saw Amir Nashat paying a total of $0.00 for 88,078 shares, this is the most they've acquired in one year. In 2024 Amir Nashat cashed out on 99,308 shares for a total of $0.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Morphic Holding, Inc.

Investor
Updated Aug 20, 2024
Form 4
-100.00%
-2.09M
Aug 20, 2024
Disposition
Aug 16
Form 4
23.17K
Jun 05, 2024
23.17K
Grant
Jun 04
Form 4
-4.78%
-99.86K
Jun 30, 2023
1.99M
Disposition
Jun 28
Form 4
12.54K
Jun 02, 2023
12.54K
Grant
Jun 01
Form 4
17.55K
Jun 10, 2022
17.55K
Grant
Jun 08
Form 4/A
9.91K
Apr 29, 2022
9.91K
Grant
Jun 16
Form 4
12.00K
Jun 17, 2021
12.00K
Grant
Jun 16
Form 4
-10.00%
-232.29K
$45.50
-$10.57M
May 25, 2021
2.09M
Sale
May 21
Form 4
12.00K
Jun 19, 2020
12.00K
Grant
Jun 18
Form 4
5.69%
125.00K
$15.00
Jul 01, 2019
2.32M
Purchase
Jul 01
Form 3
Jun 26, 2019
Showing 11 results

BIND Therapeutics, Inc

Investor
Updated Jun 10, 2015
Form 4
15.00K
Jun 10, 2015
15.00K
Grant
Jun 09
Form 4
15.00K
May 29, 2014
15.00K
Grant
May 28
Form 3
Sep 19, 2013
Showing 3 results

Receptos, Inc.

Investor
Updated Jun 05, 2014
Form 4
9.40K
Jun 05, 2014
9.40K
Grant
Jun 03
Form 4/A
-41.12%
-19.26K
Jun 03, 2014
27.59K
Disposition
May 27
Form 4
-49.25%
-379.27K
May 29, 2014
390.82K
Disposition
May 27
Form 4
-17.22%
-170.00K
$26.70
-$4.54M
Dec 10, 2013
816.94K
Sale
Dec 06
Form 4/A
-7.63%
-169.31K
$24.77
-$4.23M
Nov 22, 2013
2.05M
Sale
Nov 14 - Nov 15
Form 4
-3.02%
-30.68K
$22.77
-$698.70K
Nov 22, 2013
986.94K
Sale
Nov 20
Form 4/A
-14.26%
-169.31K
$24.96
-$4.23M
Nov 19, 2013
1.02M
Sale
Nov 14 - Nov 15
Form 4
-14.28%
-169.31K
$24.96
-$4.23M
Nov 18, 2013
1.02M
Sale
Nov 14 - Nov 15
Form 4
18.80K
Jul 19, 2013
18.80K
Grant
Jul 17
Form 4
-84.72%
-6.58M
$8.53
$10.12M
May 14, 2013
1.19M
Buy-Options
May 14
Form 3
May 08, 2013
Showing 11 results

Scholar Rock Holding Corp

Investor
Updated May 13, 2024
Form 4
-21.40%
-486.55K
May 13, 2024
1.79M
Disposition
May 09
Form 4
-45.55%
-21.33K
Dec 29, 2023
2.27M
Grant
Dec 27
Form 4
-29.77%
-973.09K
Dec 15, 2023
2.30M
Disposition
Dec 13
Form 4
-12.96%
-486.55K
Nov 22, 2023
3.27M
Disposition
Nov 20
Form 4
36.00K
Jun 22, 2023
36.00K
Grant
Jun 21
Form 4
58.74%
1.50M
$4.90
$7.34M
Jun 24, 2022
4.05M
Purchase
Jun 22
Form 4
28.00K
May 27, 2022
28.00K
Grant
May 26
Form 4
-9.73%
-275.65K
Nov 19, 2021
2.56M
Disposition
Nov 17
Form 4
7.80K
Jun 01, 2021
7.80K
Grant
May 27
Form 4
13.00K
Jun 18, 2020
13.00K
Grant
Jun 16
Form 4
10.16K
May 23, 2019
10.16K
Grant
May 21
Form 4
20.32K
Jun 26, 2018
20.32K
Grant
Jun 22
Form 4
-63.11%
-4.85M
$14.00
May 31, 2018
2.83M
Buy-Options
May 29
Form 3
May 23, 2018
Showing 14 results

FATE THERAPEUTICS INC

Investor
Updated Aug 02, 2019
Form 4
-5.16%
-62.01K
$22.53
-$1.40M
Aug 02, 2019
1.14M
Sale
ScheduledJul 31 - Aug 01
Form 4
-8.96%
-118.33K
$22.51
-$2.66M
Jul 30, 2019
1.20M
Sale
ScheduledJul 26 - Jul 30
Form 4
-5.84%
-81.90K
$22.51
-$1.84M
Jul 25, 2019
1.32M
Sale
ScheduledJul 23 - Jul 24
Form 4
-4.83%
-71.17K
$22.52
-$1.60M
Jul 22, 2019
1.40M
Sale
ScheduledJul 18 - Jul 22
Form 4
16.00K
May 07, 2019
16.00K
Grant
May 03
Form 4
-3.47%
-53.02K
$14.16
-$750.96K
Feb 01, 2019
1.47M
Sale
Jan 30
Form 4
-6.00%
-97.50K
$14.16
-$1.38M
Jan 31, 2019
1.53M
Sale
Jan 29
Form 4
-4.13%
-70.00K
$13.78
-$964.77K
Jan 30, 2019
1.62M
Sale
Jan 28
Form 4
-5.05%
-90.00K
$14.14
-$1.27M
Jan 29, 2019
1.69M
Sale
Jan 25
Form 4
-2.17%
-39.48K
$16.28
-$642.83K
Jan 23, 2019
1.78M
Sale
Jan 18
Form 4
-1.80%
-33.47K
$12.25
-$410.16K
Dec 26, 2018
1.82M
Sale
Dec 20
Form 4
-4.68%
-91.21K
$13.40
-$1.22M
Dec 21, 2018
1.86M
Sale
Dec 19
Form 4
-0.90%
-17.79K
$16.67
-$296.56K
Dec 17, 2018
1.95M
Sale
Dec 13
Form 4
-17.78%
-425.00K
$16.78
-$7.13M
Dec 14, 2018
1.97M
Sale
Dec 12
Form 4
-3.34%
-82.53K
$16.71
-$1.38M
Dec 13, 2018
2.39M
Sale
Dec 11
Form 4
16.00K
May 04, 2018
16.00K
Grant
May 02
Form 4
25.00K
May 04, 2017
25.00K
Grant
May 02
Form 4
25.00K
May 13, 2016
25.00K
Grant
May 11
Form 4/A
10.00K
May 18, 2015
10.00K
Grant
May 13
Form 4
10.00K
May 15, 2015
10.00K
Grant
May 13
Form 4
10.00K
Jun 10, 2014
10.00K
Grant
Jun 06
Form 4
4.67%
996.26K
$6.00
$5.77M
Oct 07, 2013
22.35M
Purchase
Oct 04
Form 3
Sep 30, 2013
Showing 23 results

SELECTA BIOSCIENCES INC

Investor
Updated Jun 18, 2019
Form 4
10.00K
Jun 18, 2019
10.00K
Grant
Jun 14
Form 4
72.61%
1.17M
$1.50
$1.75M
Jan 29, 2019
2.77M
Purchase
Jan 25
Form 4
10.00K
Jun 19, 2018
10.00K
Grant
Jun 15
Form 4
-4.19%
-70.23K
$18.91
-$1.33M
Sep 28, 2017
1.61M
Sale
Sep 26
Form 4
-2.28%
-79.21K
$19.13
-$1.52M
Sep 26, 2017
3.39M
Sale
Sep 22 - Sep 25
Form 4
-3.91%
-147.19K
$19.95
-$2.93M
Sep 22, 2017
3.62M
Sale
Sep 20 - Sep 21
Form 4
6.41K
Jun 20, 2017
6.41K
Grant
Jun 16
Form 4
7.03%
240.05K
$14.00
$2.10M
Jun 29, 2016
3.66M
Purchase
Jun 27
Form 3
Jun 21, 2016
40.74K
Showing 9 results

Metacrine, Inc.

Investor
Updated Sep 06, 2022
Form 4
16.50K
Sep 06, 2022
16.50K
Grant
May 18
Form 4
16.50K
May 25, 2021
16.50K
Grant
May 24
Form 4
2.97%
230.00K
$13.00
$2.99M
Sep 22, 2020
7.98M
Purchase
Sep 18
Form 3
Sep 15, 2020
Showing 4 results

Syros Pharmaceuticals, Inc.

Investor
Updated Jun 02, 2022
Form 4
17.50K
Jun 02, 2022
17.50K
Grant
Jun 01
Form 4
17.50K
Jun 10, 2021
17.50K
Grant
Jun 08
Form 4
17.50K
Jun 11, 2020
17.50K
Grant
Jun 11
Form 4
11.00K
Jun 12, 2019
11.00K
Grant
Jun 11
Form 4
11.00K
Jun 15, 2018
11.00K
Grant
Jun 14
Form 4/A
11.00K
Sep 22, 2017
11.00K
Grant
Jun 08
Form 4
11.00K
Jun 12, 2017
11.00K
Grant
Jun 08
Form 4
22.00K
Sep 19, 2016
22.00K
Grant
Sep 15
Form 4
-50.80%
-2.86M
$12.50
$5.00M
Jul 07, 2016
2.77M
Buy-Options
Jul 06
Form 3
Jun 29, 2016
Showing 10 results

aTYR PHARMA INC

Investor
Updated May 17, 2018
Form 4
20.00K
May 17, 2018
20.00K
Grant
May 15
Form 4
20.00K
May 11, 2017
20.00K
Grant
May 09
Form 4
18.00K
May 26, 2016
18.00K
Grant
May 24
Form 4
19.43K
Jan 29, 2016
19.43K
Grant
Jan 27
Form 4
6.29K
Jul 10, 2015
6.29K
Grant
Jul 08
Form 4
-87.56%
-12.87M
May 14, 2015
1.84M
Options
May 12
Form 3
May 06, 2015
12.57K
Showing 7 results

Camp4 Therapeutics Corp

Investor
Updated Oct 15, 2024
Form 4
-80.75%
-16.62M
$11.00
$10.00M
Oct 15, 2024
3.96M
Buy-Options
Oct 15
Showing 1 results